1. Timothy M. Dall, Wenya Yang,Karin Gillespie, et al.The Economic Burden of Elevated Blood Glucose Levels in 2017: Diagnosed and Undiagnosed Diabetes, Gestational Diabetes Mellitus, and Prediabetes.Diabetes Care.2019;42:1661–1668
2. Catherine C. Cowie.Diabetes Diagnosis and Control:Missed Opportunities to Improve Health.Diabetes Care. 2019;42:994–1004
3. Filla LA, Edwards JL. Metabolomics in diabetic complications. Mol Biosyst. 2016;12(4):1090-105.
4. XiantongZou, XianghaiZhou, Linong Ji, et al.The characteristics of newly diagnosed adult early-onset diabetes: a population-based cross-sectional study.SCienTiFiC ReporTS 7:46534 | DOI: 10.1038/srep46534
5. Matthew C. Riddle,Hertzel C. Gerstein.The Cardiovascular Legacy of
Good Glycemic Control: Clues About Mediators From the DCCT/EDIC Study.Diabetes Care.2019;42:1159–1161.
6. Gaballa M, Farag MK. Predictors of Diabetic Nephropathy. Eur J Med. 2013;8:287–296.
7. Richard J. MacIsaac,Elif I. Ekinci.Progression of Diabetic Kidney
Disease in the Absence of Albuminuria.Diabetes Care.2019;42:1842–1844
8. Rines AK, Sharabi K, Tavares CD, et al. Targeting hepatic glucose metabolism in the treatment of type 2 diabetes. Nat Rev Drug Discov. 2016 ;15(11):786-804.
9. Sabine Kahl, Sofiya Gancheva, Klaus Straßburger, et al. Empagliflozin Effectively Lowers Liver Fat Content in Well-Controlled Type 2 Diabetes: A
Randomized, Double-Blind, Phase4, Placebo-Controlled Trial.Diabetes Care 2020;43:298–305
10. Chen M, Zheng H, Xu M, et al. Changes in hepatic metabolic profile during the evolution of STZ-induced diabetic rats via an 1H NMR-based metabonomic investigation. Biosci Rep. 2019;39(4):BSR20181379.
11. Rai RC, Bagul PK, Banerjee SK. NLRP3 inflammasome drives inflammation in high fructose fed diabetic rat liver: Effect of resveratrol and metformin. Life Sci. 2020;15;253:117727.
12. Minzi Jua, Yaqun Liua, Mingyue Lia, et al. Baicalin improves intestinal microecology and abnormal metabolism induced by high-fat diet. European Journal of Pharmacology. 857 (2019) 172457
13. Yifei Zhang ,Yanyun Gu,Huahui Ren,et al.Gut microbiome-related effects of berberine and probiotics on type 2 diabetes (the PREMOTE study).
NATURE COMMUNICATIONS.(2020) 11:5015
14. Malik VS, Willett WC, Hu FB.Global obesity: trends, risk factors and
policy implications. Nat Rev Endocrinol .(2013)9: 13–27.
15. Shannon C, Merovci A, Xiong J, et al. Effect of Chronic Hyperglycemia on Glucose Metabolism in Subjects With Normal Glucose Tolerance. Diabetes. 2018;67(12):2507-2517.
16. Chiu THT, Pan WH, Lin MN, et al. Vegetarian diet, change in dietary patterns, and diabetes risk: a prospective study. Nutr Diabetes. 2018 ;8(1):12.
17. Taylor R, Barnes AC. Translating aetiological insight into sustainable management of type 2 diabetes. Diabetologia. 2018;61(2):273-283.
18. Biscetti F, Ferraro PM, Hiatt WR, et al. Inflammatory Cytokines Associated With Failure of Lower-Extremity Endovascular Revascularization (LER): A Prospective Study of a Population With Diabetes. Diabetes Care. 2019;42(10):1939-1945.
19. Kheiripour N, Karimi J, Khodadadi I, et al.Silymarin prevents lipid accumulation in the liver of rats with type 2 diabetes via sirtuin1 and SREBP-1c.J Basic Clin Physiol Pharmacol. 2018;29(3):301-308.
20. aylor R, Al-Mrabeh A, Sattar N. Understanding the mechanisms of reversal of type 2 diabetes. Lancet Diabetes Endocrinol.2019;7(9):726-736.
21. Bril F, Portillo Sanchez P, Lomonaco R, et al.Liver Safety of Statins in Prediabetes or T2DM and Nonalcoholic Steatohepatitis: Post Hoc Analysis of a Randomized Trial. J Clin Endocrinol Metab. 2017;102(8):2950-2961.
22. Maki Tsujita, Mohammad Anwar Hossain, Rui Lu, et al.Exposure to High Glucose Concentration Decreases Cell Surface ABCA1 and HDL Biogenesis in Hepatocytes.J Atheroscler Thromb, 2017; 24: 1132-1149
23.Sigal Leviatan,Eran Segal.Identifying gut microbes that affect human health.Nature.2020;587:373
24. Stefanie Haase,Aiden Haghikia,Nicola Wilck,et al.Impacts of microbiome metabolites on immune regulation and Autoimmunity. Immunology.2018;154:230–238
25. Rachel Botchlett,Honggui Li,XinGuo,et al.Glucose and Palmitate Differentially Regulate PFKFB3/iPFK2 and Inflammatory Responses in Mouse Intestinal Epithelial Cells.Scientific Reports.2016;6:28963
26. Leviatan S, Segal E. Identifying gut microbes that affect human health. Nature. 2020;587(7834):373-374.
27.Sittipo P, Shim JW, Lee YK. Microbial Metabolites Determine Host Health and the Status of Some Diseases. Int J Mol Sci. 2019;20(21):5296.
28. Moon Ho Do, Eunjung Lee,Mi-Jin Oh,et al.High-Glucose or -Fructose Diet Cause Changes of the Gut Microbiota and Metabolic Disorders in rats without Body Weight Change.Nutrients. 2018, 10, 761
29.Tao Zhou, Yoriko Heianza,Yuhang Chen, et al.Circulating Gut Microbiota Metabolite Trimethylamine N-Oxide (TMAO) and Changes in Bone Density in Response to Weight Loss Diets: The POUNDS Lost Trial.Diabetes Care 2019;42:1365–1371
30. Sul A Lee,Martina Cozzi,Errol L. Bush, et al.Distant Organ Dysfunction in Acute Kidney Injury: A Review.Am J Kidney Dis. 2018; 72(6): 846–856.
31. stefanie Haase, Aiden Haghikia, Nicola Wilck, et al.Impacts of microbiome metabolites on immune regulation and autoimmunity.Immunology.2018;154, 230–238
32. Jordan Whitt, Vivienne Woo, Patrick Lee, et al.Disruption of Epithelial HDAC3 in Intestine Prevents Dietinduced Obesity in rats.Gastroenterology. 2018; 155(2): 501–513.
33. Lingzhi Li,Liang Ma,Ping Fu.Gut microbiota–derived short-chain fatty acids and kidney diseases.Drug Design, Development and Therapy 2017:11 3531–3542